AVROBIO, Inc.

NASDAQ:AVRO

1.4 (USD) • At close June 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 0-3.59803.59803.598000000000000000000000000000
Cost of Revenue 01.7990-1.79901.79900.8790.923.0610.3360.354000000000000000000000
Gross Profit 0-1.79901.79901.7990-0.879-0.92-3.061-0.336-0.354000000000000000000000
Gross Profit Ratio 00.500.500.5000000000000000000000000000
Reseach & Development Expenses 13.03621.68214.3174.6820.6834.3914.82911.14817.33318.13715.91918.87719.2531923.04322.54418.52719.58728.50920.86618.27417.21913.04212.26712.44612.8099.2327.4075.6476.4655.4111.8811.434
General & Administrative Expenses 5.2622.1065.321.9677.2585.2376.2624.5817.8877.127.0668.89710.1658.9629.5778.8318.3578.4778.2097.9918.3156.2145.0224.3455.2543.86732.142.1410.9650.9590.6610.61
Selling & Marketing Expenses 00.1050-0.10500000000000000000000000000000
SG&A 5.2622.0015.322.0727.2585.2376.2624.5817.8877.127.0668.89710.1658.9629.5778.8318.3578.4778.2097.9918.3156.2145.0224.3455.2543.86732.142.1410.9650.9590.6610.61
Other Expenses 00.070-0.070-0.006-0.051-0.0360.2630.223-0.0950.005-0.045-0.2650.005-0.021-0.025-0.067-0.074-0.033-0.0160.771-0.006-0.008-0.060.655-0.005-0.002-0.0130-0.0140-0.005
Operating Expenses 18.29823.68319.6377.0797.6169.62721.09115.72925.2225.25722.98527.77429.41827.96232.6231.37526.88428.06436.71828.85726.58923.43318.06416.61217.716.67612.2329.5477.7887.436.372.5422.044
Operating Income -18.298-17.839-19.637-12.923-7.616-9.627-22.93368.007-25.22-25.257-22.985-27.774-29.418-27.962-32.62-31.375-26.884-28.064-36.718-28.857-26.589-23.433-18.064-16.612-17.7-16.676-12.232-9.547-7.788-7.43-6.37-2.542-2.044
Operating Income Ratio 000-3.5920-2.676000000000000000000000000000
Total Other Income Expenses Net 2.392-3.351.920.331.1331.2191.356-0.5310.2630.2230.016-0.28-0.415-0.2650.007-0.012-0.015-0.067-0.0620.0290.6160.7710.9190.5570.5970.6550.641-0.96-0.454-0.166-0.0710.008-0.033
Income Before Tax -15.906-21.189-17.717-12.268-6.808-8.408-21.57767.476-24.957-25.034-22.969-28.054-29.833-28.227-32.613-31.387-26.899-28.131-36.78-28.828-25.973-22.662-17.145-16.055-17.103-16.021-11.591-10.507-8.242-7.596-6.441-2.534-2.077
Income Before Tax Ratio 000-3.410-2.337000000000000000000000000000
Income Tax Expense 03.0260-3.02600.377-3.2490.459-0.839-57.603-0.1270.280.4150.489-0.002-0.009-0.01-0.309-0.012-0.062-0.632-0.245-0.925-0.565-0.657-0.184-0.6460.9580.4410.1660.057-0.0080.028
Net Income -15.906-20.812-17.717-12.645-6.808-8.785-21.57767.476-24.11832.569-22.842-28.334-30.248-28.227-32.613-31.387-26.899-28.131-36.78-28.828-25.973-22.662-17.145-16.055-17.103-16.021-11.591-10.507-8.242-7.596-6.441-2.534-2.077
Net Income Ratio 000-3.5140-2.442000000000000000000000000000
EPS -0.93-6-1.20.52-0.15-0.2-0.481.53-0.550.74-0.52-0.65-0.69-0.65-0.75-0.74-0.65-0.73-1.01-0.8-0.77-0.72-0.57-0.67-0.72-0.67-0.49-2.98-0.37-0.47-0.4-0.16-0.13
EPS Diluted -0.93-6-1.20.52-0.15-0.2-0.481.52-0.550.74-0.52-0.65-0.69-0.65-0.75-0.74-0.65-0.73-1.01-0.8-0.77-0.72-0.57-0.67-0.72-0.67-0.49-2.98-0.37-0.47-0.4-0.16-0.13
EBITDA -18.298-23.341-19.637-7.421-7.616-9.627-19.249-15.476-25.22-25.257-22.633-27.42-29.019-27.962-32.246-31.077-26.593-28.064-36.404-28.556-26.306-23.433-17.849-16.412-17.51-16.676-12.102-8.31-7.168-7.212-6.293-2.526-2.01
EBITDA Ratio 000-2.0630-2.676000000000000000000000000000